Akkeri, Inc.
Company

Akkeri, Inc.

Biotechnology Research Rare Disease 11 employees
Employees
11
Contacts
1
Emails
1

Akkeri, Inc. Overview

Headquarters
Rare Disease
Website
akkeri.com
Industry
Biotechnology Research
Employees
11
Founded
2023
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Akkeri, Inc.

Akkeri is a consulting group specializing in nonclinical drug development. We provide experienced strategic advice and operational support on drug development programs to include program design, regulatory guidance, scientific & regulatory writing (IND, NDA, CTA, MAA, IB, pre-IND), due diligence, nonclinical study planning, management & monitoring, and project team participation. We have experience across modalities such as small molecules, biologics, cell & gene therapy, and vaccines for a range of therapeutic areas and routes of administration. Our consultants bring a wealth of industry experience from biotech, large pharma, CROs, and FDA. We value a strong working relationship with clients and look forward to an opportunity to partner with your team!

Akkeri, Inc. Contact Details

People in AeroLeads
4
With contact data
1
Email contacts
1
25.0% coverage

Akkeri, Inc. Org Chart

Sample employees and titles
Name Title Contact
Ewa Budzynski, Phd, Dabt Toxicologist
View
Kristin Desouza Toxicology Professional - Drug Development - Nonclinical Safety Assessment Expert - Biotechnology & CRO Experience - Large & Small Molecules - Glps
Email
Lindsey Madara Head of Business Operations at Akkeri, Inc. ⚓️ 🧬 - Proud Military Spouse - Wfhm
View
Jacci Kleman Executive Assistant at Akkeri, Inc.
View

Employees by Management Level

Individual contributor 2 profiles
VP / Head 1 profile
Associate / junior 1 profile

Compare Similar Companies to Akkeri, Inc.